Date Published:
2006
Publication Type:
Journal Article
Authors:
Secondary:
The Journal of Neuroscience: The Official Journal of the Society for Neuroscience
Volume:
26
Pagination:
4054-62
URL:
https://pubmed.ncbi.nlm.nih.gov/
Keywords:
Animals;Binding Sites;Cerebral Cortex;Cytoskeleton;External;Fluorescent Antibody Technique;Gene Products;HIV-1;Humans;Microtubule-Associated Proteins;Neurons;Proteasome Endopeptidase Complex;Rats;Sprague-Dawley;tat;tat Gene Products
Abstract:
<p>One of the hallmarks of human immunodeficiency virus (HIV)-1 associated pathology in the CNS is deterioration of neuronal processes. Although there is mounting evidence of neuronal toxicity and cell death induced by the HIV-1 transactivating factor Tat, the molecular events linked directly to its detrimental effect on neuronal cells remain unclear. In this study, we used rat embryonic cortical neurons and demonstrated that Tat causes rapid degradation of microtubule-associated protein 2 (MAP2) and the collapse of cytoskeletal filaments. The mechanism of Tat action on MAP2 stability involved Tat-mediated translocation of the proteasome to the site of microtubule filaments. Immunohistochemical analysis of clinical samples from patients with HIV encephalopathy further revealed a significant decrease in MAP2 with predominant cytoplasmic 20S in cortical neurons near microglial nodules. These findings indicate a novel mechanism for the action of Tat on neuronal cells. It involves proteasome-mediated MAP2 degradation and may account for the loss of MAP2 and neuronal damage observed in the brain of AIDS patients with neurological dysfunctions.</p>